15 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
facilities and products except for those deemed to be “mission critical.” On March 18, 2020, the FDA announced its intention to temporarily postpone … , while foreign inspections remained limited to those deemed “mission critical.” In March 2021, the U.S. Government Accountability Office issued
424B4
AMYT
Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
capabilities.
Our Strategy
Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing … and acquiring novel rare disease products. To achieve this mission, we are pursuing the following strategies:
Drive revenue growth for our existing commercial
F-1/A
26m5dwxg8h0f atc
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
0uni3rc7kc8
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
ll16p89giaatp9dw9
18 Dec 20
Draft registration statement
12:00am
424B4
dbj7sma5q qr43ebfh
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
d4ttm8
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
e9j6cpnptw
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
u65c vym4wub
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
hcldqdg1h
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
rgrm 6sdw6tcj
11 May 20
Draft registration statement (amended)
12:00am
DRS
5crlk2 s4
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next